Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Outcome Prediction of Neoadjuvant Systemic Treatment in Esophagogastric Carcinoma

NCT03429816 is registered in ClinicalTrials.gov with University Hospital Heidelberg as lead sponsor.

NCT NCT03429816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03429816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Outcome Prediction of Neoadjuvant Systemic Treatment in Esophagogastric Carcinoma
Lead sponsor
University Hospital Heidelberg
Phase
Not applicable
Overall status
Completed
Start date
April 15, 2018
Completion date
November 30, 2023
Enrollment
120 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal adenocarcinoma, esophageal neoplasms, gastric adenocarcinoma, gastric neoplasm, gastroesophageal junction adenocarcinoma